Before taking Gilteritinib(Xospata)

Important safety information and warnings.

Essential Safety Considerations

Key precautions include the risk of differentiation syndrome, which requires immediate treatment with corticosteroids; monitoring of ECGs and electrolytes to manage QT prolongation; and advising on contraception due to embryo-fetal toxicity. Concomitant use with strong CYP3A inducers should be avoided, and caution is advised with strong CYP3A inhibitors.